Sager Pharma

What Sager Pharma does

Sager Pharma Kft. is a privately held Hungarian pharmaceutical company headquartered in Budapest, founded in 1999. Per its firmographic description, it develops and distributes therapeutics with a focus on pharmaceutical manufacturing, operating in the eye-drop and lubricants segment of the broader pharmaceutical market. The company employs between 11 and 50 people, placing it in the small-enterprise tier.

Sager Pharma operates in a regulated industry — pharmaceutical manufacturing and distribution in Hungary — which implies compliance with national and EU pharmaceutical regulatory regimes (e.g., GMP, marketing-authorization requirements for medicinal products). Its leadership consists of founder Rudolph M. Tubbeh and co-founder Gergely Kovács. The company's primary web property, sagerpharma.hu, returned only a verification/loading page in available scrapes, so no detailed product portfolio, technology stack, go-to-motion, customer list, partnership, or pricing information could be directly verified from a first-party source.

The addressable market context places Sager Pharma within the global eye-drop and lubricants market, projected at $27.78B by 2030 at a 5.1% CAGR. No company-specific revenue, market-share, geographic footprint beyond Hungary, distribution channels, or customer segments were disclosed in the input. Consequently, the company's commercial mechanics — pricing, customer mix, GTM, revenue model — are unverifiable from the supplied data, and any investment-grade inference must be flagged accordingly.

Name

Sager Pharma

Website

https://sagerpharma.hu

Company type

Private

Founded year

1999

Headcount range

11–50 employees

Short description

Sager Pharma Kft. is a privately held Budapest-based pharmaceutical company, founded in 1999, that develops and distributes therapeutics with a focus on pharmaceutical manufacturing in the eye-drop and lubricants segment, employing 11 to 50 people.

Ownership category

akta.pro rank

Product category

Ophthalmic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Ophthalmic Goods (3851), Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIACAK

Ophthalmology Specialty Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Specialty Pharmaceuticals

SECONDARYHLAIAAAL

Ophthalmology Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYHLAIAJAB

Specialty Pharmaceutical Distributors

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

• Pharmaceutical manufacturing
• Therapeutic distribution
• Eye drop formulations
• Ophthalmic products
• Pharmaceutical wholesale

Headquarters

HQ city

Budapest

HQ country

Hungary

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Core offering

Sager Pharma Kft. develops and distributes therapeutics, focusing on pharmaceutical manufacturing. The company operates within the global eye-drop and lubricants market, which is projected to reach $27.78 billion by 2030 at a 5.1% CAGR. Specific named products, formulations, or service lines were not disclosed in the available sources.

Product overview

Sager Pharma is a pharmaceutical company operating in the eye-drop and lubricants market. Based on available source data, no specific product portfolio, named offerings, or product architecture details could be extracted. The primary source (company website at http://sagerpharma.hu/) returned only a verification/loading page with no accessible product, service, or technology information.

Differentiator

Problem solved

Functional benefit

Products and services

• Therapeutic pharmaceuticals (eye-drop and lubricants segment) Therapeutic products developed and distributed by Sager Pharma, with the company placed within the global eye-drop and lubricants market (projected at $27.78 billion by 2030, 5.1% CAGR). Specific named formulations, SKUs, or product lines were not disclosed in the available sources.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves1 record

Expansion highlights1 record

Broad incumbents

• Alcon: World-leading eye-care company with a major over-the-counter and prescription ophthalmic pharmaceuticals franchise, including Systane and Tears Naturale artificial tears. Directly comparable to Sager Pharma in product category (eye drops and lubricants) but operates as a global incumbent with a much broader portfolio.
• Bausch + Lomb: Global ophthalmic pharmaceutical and device company with a broad eye-drop, lens care, and surgical portfolio. Comparable to Sager Pharma as an established ophthalmology manufacturer operating in the same eye-drop and lubricants category, though at vastly larger scale and global reach.
• Novartis (Ophthalmology / Sandoz): Global pharmaceutical major with a sizable ophthalmology franchise (formerly Alcon spinoff) including prescription eye drops such as Xiidra and a generics portfolio via Sandoz. Comparable to Sager Pharma as a broad incumbent in the ophthalmic pharmaceuticals space where Sager Pharma competes.
• Allergan (AbbVie): Owner of leading ophthalmology brands including Refresh Tears and Restasis. Competes with Sager Pharma in the ophthalmic pharmaceuticals category and represents the kind of large innovator/specialty pharma player that dominates the eye-drop market referenced in Sager Pharma's market data.

Direct peers

• Santen Pharmaceutical: Specialty pharmaceutical company focused exclusively on ophthalmology, with a portfolio of prescription eye drops for glaucoma, dry eye, and inflammation. Closely comparable to Sager Pharma as a dedicated ophthalmology therapeutics manufacturer with a similar product category and therapeutic focus.
• Théa Pharma: European independent specialty pharmaceutical company headquartered in France with a portfolio concentrated in ophthalmology, including preservative-free eye drops and dry-eye products. A strong direct peer to Sager Pharma given its European base, specialty ophthalmology focus, and similar independent/private positioning.
• Akorn Operating Company: US-based specialty pharmaceutical company with a substantial ophthalmic portfolio including prescription and OTC eye drops. Comparable to Sager Pharma as a focused ophthalmic pharmaceutical manufacturer, though Akorn operates at larger scale with US distribution.

Regional players

• Ursapharm: German-based pharmaceutical manufacturer specializing in ophthalmology, especially preservative-free eye drops and nasal sprays. Comparable to Sager Pharma as a European regional ophthalmic pharmaceutical manufacturer with overlapping therapeutic categories and a focus on eye-drop formulations.

Emerging players

• Nicox: European ophthalmology company developing and licensing novel eye-drop therapeutics for glaucoma and ocular surface disease. Comparable to Sager Pharma in the ophthalmology therapeutics category, with overlapping therapeutic focus but differentiated by R&D pipeline emphasis.
• OmniVision Pharmaceuticals: Specialty pharmaceutical company focused on ophthalmic and otic products, with a portfolio including lubricating eye drops and dry-eye treatments. Comparable to Sager Pharma as a smaller specialty ophthalmic manufacturer with overlapping product categories in eye drops and lubricants.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks1 record

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/sager-pharma-kft

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sager Pharma